Windtree Therapeutics Inc.
13F holders, Q2 2024 (June 30)5holders
$3.21avg. 13F price*
At the end of Q2 2024, 5 institutions reported holding Windtree Therapeutics Inc. in their 13F filings. The largest holders were Tower Research Capital LLC (TRC) ($5K), Bank of America Corp. ($13) and UBS Group AG ($10).
- Company
- Windtree Therapeutics Inc.
- CUSIP
- 97382D501
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $5K |
| Exits | 0 | $0 |
Ownership 5 holders
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,506 | $5K |
| Bank of America Corp. | 0.00% | New | 4 | $13 |
| UBS Group AG | 0.00% | New | 3 | $10 |
| Activest Wealth Management | 0.00% | New | 2 | $6 |
| IFP Advisors, Inc | 0.00% | New | 1 | $3 |
"% of holder's portfolio" is WINDTREE THERAPEUTICS INC's weight in each manager's 13F, not the share of Windtree Therapeutics Inc. the manager owns.